CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first ...

Moderna stock is falling after a sharp run-up in June that saw shares gain 48%.

Why Do We Think Moderna Will Underperform? Despite the momentum, we’re sitting this one out for now. Here are three reasons ...

When a stock and the analysts covering it disagree this sharply, one of them is about to be wrong.

Biotech is the story at midday Friday, and it’s not a pretty one for shareholders who chased the sector’s monster 2026 run.

Moderna's flu vaccine may not fuel a further recovery for the hard-hit COVID-19-affected stock.

The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation ...

Two of the companies are taking a second-go at FDA approval this summer, while another hopes to cement its leader-status in ...

Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. The story of the biotech company Moderna almost reads like a ...

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to report second quarter results on July 31, with investors focused on the ...

MASSACHUSETTS - Advisers to the US Food and Drug Administration on June 18 backed approval of Moderna’s flu vaccine for adults aged 50 and older, saying its benefits outweigh the risks, boosting the ...

Sanofi has sued Pfizer and Moderna , alleging that their COVID-19 vaccines infringe several of the French pharmaceutical ...